Fetal interrupted aortik ark tip B’nin antenatal değerlendirilmesi

Cilt: 42 Sayı: 2 9 Temmuz 2015
  • Ali Babacan
  • Yaşam Akpak
  • Okan Özden
  • Selami Süleymanoğlu
  • Ersin Öztürk
  • Ercüment Müngen
PDF İndir
EN TR

-

Öz

Interruption of the aortic arch (IAA) is a rare, severe form of congenital heart defect characterized by complete anatomical discontinuity between two adjacent segments of the aortic arch. The data on the features and outcomes of fetal IAA are limited. Three anatomical types have been described according to the site of interruption. The current recommendations for screening on the obstetric fetal anomaly scan include identification of a 4-chamber view, all 4 valves, and the outflow tracts, all of which can appear to be normal to the ultrasonographer in fetuses with conotruncal anomalies. Although the identification of IAA on a prenatal echocardiogram can be challenging, a number of anatomic features can facilitate the diagnosis. We aim to present the features and outcome of a case of IAA type B referred to our centre in the light of literatures

Anahtar Kelimeler

Kaynakça

  1. Vogel M, Vernon MM, McElhinney DB, et al. Fetal diagnosis
  2. of interrupted aortic arch. Am J Cardiol 2010;105:727-734.
  3. Axt-Fliedner R, Kawecki A, Enzensberger C, et al. Fetal and
  4. neonatal diagnosis of interrupted aortic arch: associations
  5. and outcomes. Fetal Diagn Ther 2011;30:299-305.
  6. Volpe P, Tuo G, De Robertis V, et al. Fetal interrupted aortic
  7. arch: 2D-4D echocardiography, associations and outcome.
  8. Ultrasound Obstet Gynecol 2010;35:302-309.

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Yaşam Akpak Bu kişi benim

Okan Özden Bu kişi benim

Selami Süleymanoğlu Bu kişi benim

Ersin Öztürk Bu kişi benim

Ercüment Müngen Bu kişi benim

Yayımlanma Tarihi

9 Temmuz 2015

Gönderilme Tarihi

9 Temmuz 2015

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2015 Cilt: 42 Sayı: 2

Kaynak Göster

APA
Babacan, A., Akpak, Y., Özden, O., Süleymanoğlu, S., Öztürk, E., & Müngen, E. (2015). -. Dicle Medical Journal, 42(2), 245-248. https://doi.org/10.5798/diclemedj.0921.2015.02.0565
AMA
1.Babacan A, Akpak Y, Özden O, Süleymanoğlu S, Öztürk E, Müngen E. -. diclemedj. 2015;42(2):245-248. doi:10.5798/diclemedj.0921.2015.02.0565
Chicago
Babacan, Ali, Yaşam Akpak, Okan Özden, Selami Süleymanoğlu, Ersin Öztürk, ve Ercüment Müngen. 2015. “-”. Dicle Medical Journal 42 (2): 245-48. https://doi.org/10.5798/diclemedj.0921.2015.02.0565.
EndNote
Babacan A, Akpak Y, Özden O, Süleymanoğlu S, Öztürk E, Müngen E (01 Temmuz 2015) -. Dicle Medical Journal 42 2 245–248.
IEEE
[1]A. Babacan, Y. Akpak, O. Özden, S. Süleymanoğlu, E. Öztürk, ve E. Müngen, “-”, diclemedj, c. 42, sy 2, ss. 245–248, Tem. 2015, doi: 10.5798/diclemedj.0921.2015.02.0565.
ISNAD
Babacan, Ali - Akpak, Yaşam - Özden, Okan - Süleymanoğlu, Selami - Öztürk, Ersin - Müngen, Ercüment. “-”. Dicle Medical Journal 42/2 (01 Temmuz 2015): 245-248. https://doi.org/10.5798/diclemedj.0921.2015.02.0565.
JAMA
1.Babacan A, Akpak Y, Özden O, Süleymanoğlu S, Öztürk E, Müngen E. -. diclemedj. 2015;42:245–248.
MLA
Babacan, Ali, vd. “-”. Dicle Medical Journal, c. 42, sy 2, Temmuz 2015, ss. 245-8, doi:10.5798/diclemedj.0921.2015.02.0565.
Vancouver
1.Ali Babacan, Yaşam Akpak, Okan Özden, Selami Süleymanoğlu, Ersin Öztürk, Ercüment Müngen. -. diclemedj. 01 Temmuz 2015;42(2):245-8. doi:10.5798/diclemedj.0921.2015.02.0565